Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2300431 | 0.77 | FFAR3 (0.38) | NPSR1 | |
| SCHEMBL12928737 | 0.77 | NPSR1 (0.37) | NPSR1ALDH1A1 | |
| SCHEMBL28023138 | 0.77 | NPSR1 (0.37) | NPSR1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL11387822 | 0.75 | FFAR3 (0.36) | NPSR1 | |
| SCHEMBL11387810 | 0.75 | NPSR1 (0.35) | NPSR1 | |
| SCHEMBL27518805 | 0.75 | NPSR1 (0.35) | NPSR1 | |
| SCHEMBL2771351 | 0.75 | LMNA (0.37) | NPSR1ALDH1A1 | |
| SCHEMBL19233 | 0.75 | CYP2C19 (0.38) | NPSR1ALDH1A1 | |
| SCHEMBL2775123 | 0.75 | NPSR1 (0.50) | NPSR1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL8362281 | 0.73 | CYP2C19 (0.37) | NPSR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4130006-A1 | ANTI-PSMA ANTIBODY-EXATECAN ANALOGUE CONJUGATE AND MEDICAL USE THEREOF | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2023-02-08 | — | — | EP | disclosed |
| EP-3981434-A1 | ANTI-B7-H4 ANTIBODY-DRUG CONJUGATE AND MEDICINAL USE THEREOF | Shanghai Hansoh Biomedical Co., Ltd. (CN) | 2022-04-13 | — | — | EP | disclosed |
| WO-2022068914-A1 | PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY-DRUG CONJUGATE, AND USE OF PHARMACEUTICAL COMPOSITION | 江苏恒瑞医药股份有限公司 | 2022-04-07 | — | — | WO | disclosed |
| WO-2021147993-A1 | ANTI-TROP-2 ANTIDODY-EXATECAN ANALOG CONJUGATE AND MEDICAL USE THEREOF | 江苏恒瑞医药股份有限公司 | 2021-07-29 | — | — | WO | disclosed |
| EP-3854816-A1 | ANTI-B7H3 ANTIBODY-EXATECAN ANALOG CONJUGATE AND MEDICINAL USE THEREOF | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2021-07-28 | — | — | EP | disclosed |
| WO-2021121204-A1 | ANTI-CEA ANTIBODY-EXATECAN ANALOG CONJUGATE AND PHARMACEUTICAL USE THEREOF | 江苏恒瑞医药股份有限公司 | 2021-06-24 | — | — | WO | disclosed |
| WO-2021115426-A1 | ANTI-CLAUDIN ANTIBODY-DRUG CONJUGATE AND PHARMACEUTICAL USE THEREOF | 江苏恒瑞医药股份有限公司 | 2021-06-17 | — | — | WO | disclosed |
| WO-2020244657-A1 | ANTI-B7-H4 ANTIBODY–DRUG CONJUGATE AND MEDICINAL USE THEREOF | 上海翰森生物医药科技有限公司 | 2020-12-10 | — | — | WO | disclosed |
| WO-2020063673-A1 | ANTI-B7H3 ANTIBODY-EXATECAN ANALOG CONJUGATE AND MEDICINAL USE THEREOF | 江苏恒瑞医药股份有限公司 | 2020-04-02 | — | — | WO | disclosed |
| WO-2020063676-A1 | LIGAND-DRUG CONJUGATE OF EXATECAN ANALOGUE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 江苏恒瑞医药股份有限公司 | 2020-04-02 | — | — | WO | disclosed |